WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016056596) HSP70-DERIVED PEPTIDE, AND METHOD OF MANUFACTURING PHARMACEUTICAL COMPOSITION, IMMUNITY INDUCER, AND ANTIGEN-PRESENTING CELL FOR CANCER TREATMENT OR PREVENTION USING THE SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2016/056596 International Application No.: PCT/JP2015/078504
Publication Date: 14.04.2016 International Filing Date: 07.10.2015
IPC:
C07K 7/06 (2006.01) ,A61K 38/00 (2006.01) ,A61K 39/00 (2006.01) ,A61K 47/48 (2006.01) ,A61P 35/00 (2006.01) ,A61P 37/04 (2006.01) ,C12N 5/0784 (2010.01) ,C12N 15/09 (2006.01)
Applicants: CYTLIMIC INC.[JP/JP]; 15-19, Kamiosaki 2-chome, Shinagawa-ku, Tokyo 1410021, JP
Inventors: MIYAKAWA, Tomoya; JP
OKA, Masaaki; JP
HAZAMA, Shoichi; JP
TAMADA, Koji; JP
UDAKA, Keiko; JP
Agent: INABA, Yoshiyuki; JP
Priority Data:
2014-20673007.10.2014JP
Title (EN) HSP70-DERIVED PEPTIDE, AND METHOD OF MANUFACTURING PHARMACEUTICAL COMPOSITION, IMMUNITY INDUCER, AND ANTIGEN-PRESENTING CELL FOR CANCER TREATMENT OR PREVENTION USING THE SAME
(FR) PEPTIDE DÉRIVÉ DE HSP70, ET PROCÉDÉ DE FABRICATION DE COMPOSITION PHARMACEUTIQUE, INDUCTEUR D'IMMUNITÉ, ET CELLULE PRÉSENTATRICE D'ANTIGÈNE PERMETTANT LE TRAITEMENT OU LA PRÉVENTION DU CANCER L'UTILISANT
(JA) HSP70由来のペプチド、これを用いた癌の治療又は予防のための医薬組成物、免疫誘導剤、及び抗原提示細胞の製造方法
Abstract: front page image
(EN) The present invention provides a peptide including continuous 8 or more amino acid residues from an amino acid sequence represented by any of SEQ ID NO. 1 to 15, and consisting of 11 or less amino acid residues.
(FR) La présente invention concerne un peptide comprenant en 8 résidus d'acides aminés continus ou plus d'une séquence d'acides aminés représentée par l'une quelconque de SEQ ID NO. 1 à 15, et constitué de 11 résidus d'acides aminés ou moins.
(JA) 本発明は、配列番号1~15のいずれかで表されるアミノ酸配列における連続した8以上のアミノ酸残基を含み、且つ11以下のアミノ酸残基から成るペプチド、を提供する。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)